Top Markets
#1 DogBull DogBull +105.02%
#2 Siacoin Siacoin +53.17%
#3 ADO Protocol ADO Protocol +46.57%
#4 UnifAI Network UnifAI Network +44.82%
#5 MarsCoin MarsCoin +42.26%
#6 Useless Coin Useless Coin +23.51%
#7 Magma Finance Magma Finance +22.41%
#8 Ontology Gas Ontology Gas +20.59%
#9 Cash Cat Cash Cat +15.71%
#10 Apertum Apertum +14.51%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Clasificación en acciones #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Precio por acción
$7.15
Capitalización bursátil
$313.60M
Cambio (1 día)
-2.12%
Cambio (1 año)
-84.14%
País
DE
Comercio Anbio Biotechnology Class A Ordinary Shares (NNNN)

Categoría

Healthcare
Ganancias de Anbio Biotechnology Class A Ordinary Shares (NNNN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Anbio Biotechnology Class A Ordinary Shares, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Anbio Biotechnology Class A Ordinary Shares desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
$3.81B -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
$4.11B -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
- -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
$1.59B -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
- -
CH